AIFM3 and cancer: Similarly, the upregulation of WNT4, a key mediator of epithelial–mesenchymal transition, suggests its role in promoting metastasis and its potential as a therapeutic target, while the reduction of AIFM3-positive cells in CRC compared to other cancers highlights its potential role in restoring apoptotic pathways.